Cure Pharmaceutical Holding Corp. Logo

Cure Pharmaceutical Holding Corp. (IFIN)

NYSE

Currency in USD
3.51
-0.34 (-8.83%)

Closed

Aug 21, 2026

Day's Range

3.45
3.95

52 wk Range

1.31
4.72

Profile - IFIN - Cure Pharmaceutical Holding Corp.

Profile

Mic Code

XNYS

Sector

Technology

Industry

Software - Application

Employees

244


Cure Pharmaceutical Holding Corp. is a biopharmaceutical company focused on the development and commercialization of innovative drug delivery systems. It aims to improve patient adherence and experience by providing new methods for drug delivery, such as oral thin films and transdermal systems. Cure Pharmaceutical's technologies are designed to enhance the bioavailability, efficacy, and safety of existing pharmaceutical compounds while also providing a platform for new drug formulations. This plays a vital role in several therapeutic areas, including pain management, oncology, and central nervous system disorders. By leveraging cutting-edge technology and partnerships within the pharmaceutical industry, Cure Pharmaceutical Holding Corp. contributes to the advancement of personalized and precision medicine, addressing unmet medical needs and broadening the spectrum of delivery options in healthcare markets.

Profile Details

Type

Common Stock

Ceo

Mr. King Ong Kong

Address

410 North Bridge Road

City

Singapore

State

NY

Zip

188726

Country

Singapore

Phone

65 6407 7362

Key Executives - IFIN - Cure Pharmaceutical Holding Corp.

Key executives

NamePositionAgePay
Mr. Alexander EdgarovCEO & Director46-
Mr. Sheldon BrickmanChief Financial Officer57-

Cross Listings - IFIN - Cure Pharmaceutical Holding Corp.

Also listed on

The same company trading on other exchanges.

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.